Ephion Health is officially joining the Innovative Health Initiative (IHI) Project PaLaDIn, a €21 million European consortium dedicated to transforming rare disease care. By integrating its AI-powered digital biomarker platform with PaLaDIn’s state-of-the-art "Interactium," Ephion will contribute its expertise in objective functional assessment and wearable data analysis. This collaboration aims to bridge the gap in patient data for neuromuscular diseases, empowering patients and providing researchers with the real-world evidence needed to accelerate the development of life-changing treatments.

‍

https://www.project-paladin.eu/

‍